RepliCel Life Sciences Inc.
RP
Pozycja w akcjach
#38680
Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a... Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.
Cena akcji
$0.01100905
Ostatnia synchronizacja: 2025-02-28
Kapitalizacja rynkowa
$810.02K
Zmiana (1 dzień)
58.98%
Zmiana (1 rok)
10,909.05%
Kraj
CA
Handel RepliCel Life Sciences Inc. (RP)
Kategoria
Healthcare
Kapitalizacja rynkowa RepliCel Life Sciences Inc.(RP)
Kapitalizacja rynkowa: $810.02K
Na dzień October 2026 spółka RepliCel Life Sciences Inc. ma kapitalizację rynkową wynoszącą $810.02K. Według naszych danych, czyni to RepliCel Life Sciences Inc. 38680th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej RepliCel Life Sciences Inc. od 2010 do 2026
RP w porównaniu do 5 najpopularniejszych stocks
| Cena za RP | Aktywa B | Kapitalizacja rynkowa B | Wyniki | |
|---|---|---|---|---|
$70,232.98
$7.36K
|
$5.167T | +70,232,975,297.58% | ||
|
$68,163.37
$7.36K
|
$5.015T | +68,163,370,305.06% | ||
|
$55,843.44
$7.36K
|
$4.108T | +55,843,444,607.63% | ||
|
$53,036.61
$7.36K
|
$3.902T | +53,036,614,804.17% | ||
|
$36,556.42
$7.36K
|
$2.689T | +36,556,422,925.69% |
